Lupin’s arm recalling 39,216 bottles of Lisinopril & Hydrochlorothiazide tablets from US

26 Aug 2019 Evaluate

Lupin’s American subsidiary -- Lupin Pharmaceuticals Inc is recalling 39,216 bottles of Lisinopril and Hydrochlorothiazide tablets USP, 10 mg/12.5 mg, 100 tablet bottle manufactured at its Pithampur facility from the US market. The reason for the recall is presence of foreign substance; product complaints received related to brownish/blackish stains on the tablets and brownish/blackish powder observed inside the bottles. The tablets are used for treatment of hypertension.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2117.95 28.30 (1.35%)
17-Dec-2025 12:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1785.00
Dr. Reddys Lab 1277.70
Cipla 1492.85
Zydus Lifesciences 918.80
Lupin 2117.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×